More like:
Optimising patient specific treatment plans for ultrasound ablative therapies in the abdomen (OptimUS) [Clear]

# Title Funder Funding Start End Status
1 Optimising patient specific treatment plans for ultrasound ablative therapies in the abdomen (OptimUS) EPSRC
£1,413,606
 March 31, 2017 June 29, 2021 Closed
2 Optimising patient specific treatment plans for ultrasound ablative therapies in the abdomen (OptimUS) EPSRC
£3,534,015
 March 31, 2017 June 30, 2021 Closed
3 Integrated Microwave Amplifiers for Electrosurgical Applications EPSRC
£496,215
 April 26, 2016 May 31, 2017 Closed
4 Therapy Ultrasound Network for Drug Delivery & Ablation Research (ThUNDDAR) EPSRC
£1,351,718
 Aug. 31, 2016 Aug. 30, 2021 Closed
5 Therapy Ultrasound Network for Drug Delivery & Ablation Research (ThUNDDAR) EPSRC
£3,379,295
 Aug. 31, 2016 Aug. 31, 2021 Closed
6 Development of Targeted Cancer Cell Hyperthermia Technique EPSRC
£0
 Sept. 30, 2021 Sept. 29, 2024 Active
7 Development of Targeted Cancer Cell Hyperthermia Technique EPSRC
£0
 Sept. 30, 2021 Sept. 30, 2024 Active
8 Invited Resubmission: Improved Organ Dose Determination and Imaging in 177Lu Targeted Radionuclide Therapy - towards a clinical solution. STFC
£977,330
 Sept. 30, 2012 Sept. 30, 2014 Closed
9 Magnetically-Activated Nucleic Acids EPSRC
£0
 Sept. 30, 2021 Sept. 29, 2025 Active
10 Magnetically-Activated Nucleic Acids EPSRC
£0
 Sept. 30, 2021 Sept. 30, 2025 Active
11 REVing-down: targeting the circadian clock in metabolic disease MRC
£1,159,254
 Feb. 1, 2017 May 28, 2020 Closed
12 Demonstration of the potential application of Agluna anti-infective surface treatment technology to cardiac pacemakers Innovate UK
£150,534
 March 1, 2012 March 31, 2013 Closed
13 Miniature Ultrasonic Cutting Devices for High Precision Minimal Access Orthopaedic Surgical Procedures EPSRC
£370,784
 Feb. 1, 2010 April 29, 2013 Closed
14 Miniature Ultrasonic Cutting Devices for High Precision Minimal Access Orthopaedic Surgical Procedures EPSRC
£830,632
 Nov. 1, 2009 Dec. 31, 2012 Closed
15 Miniature Ultrasonic Cutting Devices for High Precision Minimal Access Orthopaedic Surgical Procedures EPSRC
£666,806
 Feb. 8, 2010 Feb. 7, 2014 Closed
16 The role of P21/Cdc42/Rac1-activated kinases (PAK) in prostate cancer. MRC
£370,800
 Sept. 29, 2012 Sept. 28, 2015 Closed
17 The role of P21/Cdc42/Rac1-activated kinases (PAK) in prostate cancer. MRC
£927,000
 Sept. 29, 2012 Sept. 29, 2015 Closed
18 GoGREEN: REDUCING THE ENVIRONMENTAL IMPACT OF OPERATING THEATRES - A BEHAVIOURAL SCIENCE APPROACH MRC
£100,781
 Oct. 13, 2022 Oct. 12, 2023 Active
19 Novel PET imaging STFC
£432,665
 Aug. 31, 2012 Feb. 28, 2014 Closed
20 Engineered Near-infrared Light Sensitive Nanovesicles for Precise Image-Guided Thermally Triggered Cancer Therapy MRC
£0
 Sept. 30, 2016 Jan. 27, 2017 Closed
Reset